한글목차

세계의 당뇨병 관리 기기 시장 규모는 2024년 166억 달러에서 2024년부터 2029년까지 예측 기간 동안 10.1%의 연평균 복합 성장률(CAGR)로 성장하여 2029년 말에는 268억 달러에 달할 것으로 예상됩니다.

세계 연속 혈당 모니터링(CGM) 시스템 시장 규모는 2024년 111억 달러에서 예측 기간 동안 13.4%의 연평균 복합 성장률(CAGR)을 기록하며 2029년 말 209억 달러에 이를 것으로 예상됩니다. 또한, 세계 자가혈당측정(SMBG) 기기 시장 규모는 2024년 55억 달러에서 2029년 말까지 1.7%의 연평균 복합 성장률(CAGR)로 59억 달러로 성장할 것으로 예측됩니다.

세계의 당뇨병 관리 기기(Diabetes Care Device) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이와 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 시장의 정의
• 당뇨병
• 당뇨병 유형
• 자기 모니터링 당뇨병 관리 기기

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 당뇨병 이환율 증가
• 고령화 인구 증가
• 보다 우수한 개인용 당뇨병 관리 툴 수요
• 의료 및 상환 정책
• 예방 헬스케어에 대한 주목
• 시장 성장 억제요인
• 지속적 데이터 결여
• CGM 고비용
• 저소득 지역에서의 액세스상 제약
• 시장 기회
• 당뇨병 관리 솔루션의 필요성
• 파트너십
• 시장이 해결해야 할 과제
• 혈당 측정기와 CGM의 정확도 부족

제4장 신기술과 개발

• 개요
• 이식형 CGM 기술
• CGM 모니터링 AI의 통합
• 비침습성 CGM 시스템
• 임상시험

제5장 시장 세분화 분석

• 세분화 내역
• 세계의 당뇨병 모니터링 디바이스 시장 : 유형별
• 자기 혈당 측정(SMBG) 디바이스
• 연속 혈당 모니터링(CGM) 시스템
• 지역별 분석
• 세계의 당뇨병 모니터링 디바이스 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 남미
• 기타 지역

제6장 경쟁 정보

• 업계 시나리오
• 경쟁 구도

제7장 당뇨병 관리 기기 시장의 지속가능성 : ESG 관점

• ESG : 서론
• ESG 성과 분석
• 환경 성과
• 사회적 성과
• 거버넌스 성과
• BCC의 결론

제8장 부록

• 조사 방법
• 참고 문헌
• 약어
• 기업 개요
• ABBOTT
• ACON LABORATORIES INC.
• AGAMATRIX
• ARKRAY INC.
• B. BRAUN SE
• DEXCOM INC.
• F. HOFFMANN-LA ROCHE LTD.
• I-SENS INC.
• LIFESCAN IP HOLDINGS LLC.
• MEDTRONIC
• PHC HOLDINGS CORP.
• SENSEONICS
• SINOCARE
• TERUMO CORP.
• YPSOMED

영문목차

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

The global market for continuous glucose monitoring systems is expected to grow from $11.1 billion in 2024 to $20.9 billion by the end of 2029, at a CAGR of 13.4% from 2024 through 2029.

The global market for self-monitoring blood glucose devices is expected to grow from $5.5 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 1.7% from 2024 through 2029.

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

Self-monitoring blood glucose (SMBG) devices:

• Blood glucose meter devices.
• Blood glucose test strips.
• Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

• Sensors and transmitters.
• Receivers.

End users:

• Hospitals.
• Home care settings.
• Diagnostic centers.

Report Includes:

• 30 data tables and 47 additional tables
• An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems
• Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region
• Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances
• Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Patent analysis featuring key granted and published patents
• Emerging new developments and clinical trials in the diabetes care market
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Definitions
• Diabetes Mellitus
• Types of Diabetes
• Self-Monitoring Diabetic Care Devices

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Prevalence of Diabetes
• Increasing Aging Population
• Demand for Better Personal Diabetes Management Tools
• Healthcare and Reimbursement Policies
• Increasing Focus on Preventive Healthcare
• Market Restraints
• Lack of Continuous Data
• High Cost of CGMs
• Limited Access in Low-Income Regions
• Opportunities in the Market
• Need for Diabetes Management Solutions
• Partnerships
• Market Challenges
• Lack of Glucose Meter and CGM Accuracy

Chapter 4 Emerging Technologies and Developments

• Overview
• Implantable CGM Technology
• AI Integration in CGM Monitoring
• Non-Invasive CGM System
• Clinical Trials

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market for Diabetes Monitoring Devices, by Type
• Self-Monitoring Blood Glucose (SMBG) Devices
• Continuous Glucose Monitoring (CGM) Systems
• Geographic Breakdown
• Global Market for Diabetes Monitoring Devices, by Region
• North America
• Europe
• Asia-Pacific
• South America
• Rest of the World

Chapter 6 Competitive Intelligence

• Industry Scenario
• Competitive Landscape

Chapter 7 Sustainability in the Diabetic Care Devices Market: An ESG Perspective

• Introduction to ESG
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• ABBOTT
• ACON LABORATORIES INC.
• AGAMATRIX
• ARKRAY INC.
• B. BRAUN SE
• DEXCOM INC.
• F. HOFFMANN-LA ROCHE LTD.
• I-SENS INC.
• LIFESCAN IP HOLDINGS LLC.
• MEDTRONIC
• PHC HOLDINGS CORP.
• SENSEONICS
• SINOCARE
• TERUMO CORP.
• YPSOMED